Skip to content
Ingenia Therapeutics Logo Ingenia Therapeutics Logo Ingenia Therapeutics Logo
  • Home
  • About
    • Company Overview
    • Leadership
    • Scientific Advisory Board
  • Science
    • Ingenia’s Science
    • Research Areas of Focus
  • Pipeline
  • Careers
  • Contact
  • Home
  • About
    • Company Overview
    • Leadership
    • Scientific Advisory Board
  • Science
    • Ingenia’s Science
    • Research Areas of Focus
  • Pipeline
  • Careers
  • Contact

Events and Presentations

Events and PresentationsJayashree Paranjape2022-05-03T15:25:34+00:00

Variants of IGT-427 are long-acting, bispecific antibodies for the treatment of degenerative retinal diseases

Read More
Copyright ©2021 Ingenia Therapeutics
FacebookTwitterLinkedIn
Page load link